• 1
    Hubert, H. B., Feinleib, M., McNamara, P. M., Castelli, W. P. (1983) Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67: 968977.
  • 2
    Hulthe, J., Bokemark, L., Wikstrand, J., Fagerberg, B. (2000) The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol 20: 21402147.
  • 3
    Isomaa, B., Almgren, P., Tuomi, T., et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683689.
  • 4
    Maffei, M., Halaas, J., Ravussin, E., et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 11551161.
  • 5
    Considine, R. V., Sinha, M. K., Heiman, M. L., et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292295.
  • 6
    Wallace, A. M., McMahon, A. D., Packard, C. J., et al. (2001) Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104: 30523056.
  • 7
    Zimmet, P., Boyko, E. J., Collier, G. R., de Courten, M. (1999) Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann N Y Acad Sci 892: 2544.
  • 8
    Leyva, F., Godsland, I. F., Ghatei, M., et al. (1998) Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18: 928933.
  • 9
    Wang, J., Obici, S., Morgan, K., Barzilai, N., Feng, Z., Rossetti, L. (2001) Overfeeding rapidly induces leptin and insulin resistance. Diabetes 50: 27862791.
  • 10
    Martin, R. L., Perez, E., He, Y. J., Dawson, R. Jr, Millard, W. J. (2000) Leptin resistance is associated with hypothalamic leptin receptor mRNA and protein down regulation. Metabolism 49: 14791484.
  • 11
    Scarpace, P. J., Matheny, M., Tumer, N. (2001) Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats. Neuroscience 104: 11111117.
  • 12
    Wang, Z., Zhou, Y. T., Kakuma, T., et al. (2000) Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling. Biochem Biophys Res Commun 277: 2026.
  • 13
    Correia, M. L., Haynes, W. G., Rahmouni, K., Morgan, D. A., Sivitz, W. I., Mark, A. L. (2002) The concept of selective leptin resistance: evidence from agouti yellow obese mice. Diabetes 51: 439442.
  • 14
    Lammert, A., Kiess, W., Bottner, A., Glasow, A., Kratzsch, J. (2001) Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 283: 982988.
  • 15
    Yamaguchi, M., Murakami, T., Yasui, Y., et al. (1998) Mouse placental cells secrete soluble leptin receptor (sOB-R): cAMP inhibits sOB-R production. Biochem Biophys Res Commun 252: 363367.
  • 16
    Maamra, M., Bidlingmaier, M., Postel-Vinay, M. C., Wu, Z., Strasburger, C. J., Ross, R. J. (2001) Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology 142: 43894393.
  • 17
    van Dielen, F. M., van't Veer, C., Buurman, W. A., Greve, J. W. (2002) Leptin and soluble leptin receptor levels in obese and weight-losing individuals. J Clin Endocrinol Metab 87: 17081716.
  • 18
    Laimer, M., Ebenbichler, C. F., Kaser, S., et al. (2002) Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin. Obes Res 10: 597601.
  • 19
    Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412419.
  • 20
    Alberti, K. G., Zimmet, P. Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications: I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539553.
  • 21
    Sinha, M. K., Opentanova, I., Ohannesian, J. P., et al. (1996) Evidence of free and bound leptin in human circulation: studies in lean and obese subjects and during short-term fasting. J Clin Invest 98: 12771282.
  • 22
    Houseknecht, K. L., Mantzoros, C. S., Kuliawat, R., Hadro, E., Flier, J. S., Kahn, B. B. (1996) Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 45: 16381643.
  • 23
    Uotani, S., Bjorbaek, C., Tornoe, J., Flier, J. S. (1999) Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor down regulation. Diabetes 48: 279286.
  • 24
    Wang, Z. W., Zhou, Y. T., Kakuma, T., et al. (1999) Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemia. Proc Natl Acad Sci USA 96: 1037310378.
  • 25
    Chan, J. L., Bluher, S., Yiannakouris, N., Suchard, M. A., Kratzsch, J., Mantzoros, C. S. (2002) Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 51: 21052112.
  • 26
    Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 24862497.
  • 27
    Bonora, E., Targher, G., Alberiche, M., et al. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23: 626640.
  • 28
    Baumann, G., Shaw, M. A., Amburn, K. (1994) Circulating growth hormone binding proteins. J Endocrinol Invest 17: 6781.
  • 29
    Barnard, R., Waters, M. J. (1997) The serum growth hormone binding protein: pregnant with possibilities. J Endocrinol 153: 114.